Wild type transthyretin amyloidosis: real-life experience of tafamidis use and frailty analysis of treated patients

10 May 2026 (08:30 - 09:15)
Organised by: Logo
Congress Presentation Part of: Evolving management of cardiomyopathies: early detection, precision diagnostics, and emerging treatments Chronic Nursing Care Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by